The sirtuins promote Dishevelled-1 scaffolding of TIAM1, Rac activation and cell migration.

Abstract:

:Rac1-GTPases serve as intermediary cellular switches, which conduct transient and constitutive signals from upstream cues, including those from Ras oncoproteins. Although the sirtuin1 (SIRT1) deacetylase is overexpressed in several human cancers and has recently been linked to cancer cell motility as a context-dependent regulator of multiple pathways, its role in Rac1 activation has not been reported. Similarly, SIRT2 has been demonstrated to be upregulated in some cancers; however, studies have also reported its role in tumor suppression. Here, we demonstrate that SIRT1 and SIRT2 positively regulate the levels of Rac1-GTP and the activity of T-cell lymphoma invasion and metastasis 1 (TIAM1), a Rac guanine nucleotide exchange factor (GEF). Transient inhibition of SIRT1 and SIRT2 resulted in increased acetylation of TIAM1, whereas chronic SIRT2 knockdown resulted in enhanced acetylation of TIAM1. SIRT1 regulates Dishevelled (DVL) protein levels in cancer cells, and DVL along with TIAM1 are known to augment Rac activation; however, SIRT1 or 2 has not been previously linked with TIAM1. We found that diminished sirtuin activity led to the disruption of the DVL1-TIAM1 interaction. We hence propose a model for Rac activation where SIRT1/2 positively modulates the DVL/TIAM1/Rac axis and promotes sustained pathway activation.

journal_name

Oncogene

journal_title

Oncogene

authors

Saxena M,Dykes SS,Malyarchuk S,Wang AE,Cardelli JA,Pruitt K

doi

10.1038/onc.2013.549

subject

Has Abstract

pub_date

2015-01-08 00:00:00

pages

188-98

issue

2

eissn

0950-9232

issn

1476-5594

pii

onc2013549

journal_volume

34

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.

    abstract::The mouse pancreatic amylase Amy-2.2 gene was fused to the structural gene for SV40 T antigen, and 51 independent transgenic founder mice carrying the fusion gene were generated. The majority of the founders and 100% of their offspring in the derived transgenic lines developed pancreatic acinar cell carcinomas and sto...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ceci JD,Kovatch RM,Swing DA,Jones JM,Snow CM,Rosenberg MP,Jenkins NA,Copeland NG,Meisler MH

    更新日期:1991-02-01 00:00:00

  • The consistent 13q14 translocation breakpoint seen in chronic B-cell leukaemia (BCLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene.

    abstract::Structural rearrangements involving chromosome 13 are frequently seen in B-cell chronic lymphocytic leukaemia. The presence of reciprocal translocations involving 13q14 in 10-15% of cases pinpoints the location of a gene important in leukaemogenesis. In order to characterise the exact location of the 13q14 breakpoint,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hawthorn LA,Chapman R,Oscier D,Cowell JK

    更新日期:1993-06-01 00:00:00

  • Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src.

    abstract::In previous studies examining the role of pp60c-src in cellular proliferation, we demonstrated that overexpression of wild type (wt) but not mutated c-src in C3H10T1/2 murine embryo fibroblasts resulted in a 2 to 5 fold enhancement of DNA synthesis in response to epidermal growth factor (EGF). Using phosphotyrosine an...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wilson LK,Parsons SJ

    更新日期:1990-10-01 00:00:00

  • Direct integrin alphavbeta6-ERK binding: implications for tumour growth.

    abstract::Blockade of the mitogen-activated protein (MAP) kinase pathway suppresses growth of colon cancer in vivo. Here we demonstrate a direct link between the extracellular signal-regulated kinase ERK2 and the growth-promoting cell adhesion molecule, integrin alphavbeta6, in colon cancer cells. Down-regulation of beta6 integ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205286

    authors: Ahmed N,Niu J,Dorahy DJ,Gu X,Andrews S,Meldrum CJ,Scott RJ,Baker MS,Macreadie IG,Agrez MV

    更新日期:2002-02-21 00:00:00

  • Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells.

    abstract::Apoptosis resistance is crucially involved in cancer development and progression, represents the leading cause for failure of anticancer therapy and is caused, for example, by downregulation of proapoptotic intracellular signaling molecules such as caspase-8. We found that the cytotoxic drugs methotrexate (MTX) and 5-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210666

    authors: Ehrhardt H,Häcker S,Wittmann S,Maurer M,Borkhardt A,Toloczko A,Debatin KM,Fulda S,Jeremias I

    更新日期:2008-01-31 00:00:00

  • The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus.

    abstract::B7-H4, a member of B7 family, is a transmembrane protein and inhibits T-cells immunity. However, in a variety of tumor cells, B7-H4 was detected predominantly in intracellular compartments with unknown mechanism and functions. In this study, we analyzed B7-H4 expression and subcellular distribution by immunohistochemi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.600

    authors: Zhang L,Wu H,Lu D,Li G,Sun C,Song H,Li J,Zhai T,Huang L,Hou C,Wang W,Zhou B,Chen S,Lu B,Zhang X

    更新日期:2013-11-14 00:00:00

  • Stimulation by hydrogen peroxide of DNA synthesis, competence family gene expression and phosphorylation of a specific protein in quiescent Balb/3T3 cells.

    abstract::Treatment of quiescent Balb/3T3 clone A31-1-1 cells with 0.1-0.2 mM H2O2 in the presence of 1 microM insulin induced DNA synthesis 20-24 h later at almost the same level as that in cells treated with 10% serum. Treatment with 0.1-0.2 mM H2O2 alone did not induce DNA synthesis and was not toxic to the cells. Cell cycle...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Shibanuma M,Kuroki T,Nose K

    更新日期:1990-07-01 00:00:00

  • Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation.

    abstract::The transcriptional activity of the androgen receptor (AR) is regulated by both ligand binding and post-translational modifications, including acetylation and small ubiquitin-like modifier (SUMO)ylation. Histone deacetylases (HDACs) are known to catalyze the removal of acetyl groups from both histones and non-histone ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.600

    authors: Yang Y,Tse AK,Li P,Ma Q,Xiang S,Nicosia SV,Seto E,Zhang X,Bai W

    更新日期:2011-05-12 00:00:00

  • Cytokine control of developmental programs in normal hematopoiesis and leukemia.

    abstract::The establishment of a system for in vitro clonal development of hematopoietic cells made it possible to discover the cytokines that regulate hematopoiesis. These cytokines include colony stimulating factors and others, which interact in a network, and there is a cytokine cascade which couples growth and differentiati...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205319

    authors: Lotem J,Sachs L

    更新日期:2002-05-13 00:00:00

  • Rho GTPases: Anti- or pro-neoplastic targets?

    abstract::Rho GTPases are critical signal transducers of multiple pathways. They have been proposed to be useful anti-neoplastic targets for over two decades, especially in Ras-driven cancers. Until recently, however, few in vivo studies had been carried out to test this premise. Several recent mouse model studies have verified...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.473

    authors: Zandvakili I,Lin Y,Morris JC,Zheng Y

    更新日期:2017-06-08 00:00:00

  • Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients.

    abstract::Imatinib-acquired resistance related to the presence of secondary point mutations has become a frequent event in gastrointestinal stromal tumors. Here, transient transfection experiments with plasmids carrying two different KIT-acquired point mutations were performed along with immunoprecipitation of total protein ext...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209639

    authors: Tamborini E,Pricl S,Negri T,Lagonigro MS,Miselli F,Greco A,Gronchi A,Casali PG,Ferrone M,Fermeglia M,Carbone A,Pierotti MA,Pilotti S

    更新日期:2006-10-05 00:00:00

  • Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients.

    abstract::Tyrosine kinase inhibitor (TKI)-sensitive and TKI-resistant mutations of epidermal growth factor receptor (EGFR) are associated with lung adenocarcinoma. EGFR mutants were previously shown to exhibit ligand-independent activation. We have previously demonstrated that pulmonary surfactant protein D (SP-D, SFTPD) suppre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.253

    authors: Umeda Y,Hasegawa Y,Otsuka M,Ariki S,Takamiya R,Saito A,Uehara Y,Saijo H,Kuronuma K,Chiba H,Ohnishi H,Sakuma Y,Takahashi H,Kuroki Y,Takahashi M

    更新日期:2017-11-16 00:00:00

  • CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development.

    abstract::Lung cancer is one of the major causes of cancer death and clarification of its molecular pathology is highly prioritized. The physiological importance of mRNA degradation through the CCR4-NOT deadenylase has recently been highlighted. For example, mutation in CNOT3, a gene coding for CNOT3 subunit of the CCR4-NOT com...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0603-7

    authors: Shirai YT,Mizutani A,Nishijima S,Horie M,Kikuguchi C,Elisseeva O,Yamamoto T

    更新日期:2019-04-01 00:00:00

  • ELAS1-mediated inhibition of the cyclin G1-B'γ interaction promotes cancer cell apoptosis via stabilization and activation of p53.

    abstract::Radiation therapy (RT) is useful for selectively killing cancer cells. However, because high levels of ionizing radiation (IR) are toxic to normal cells, RT cannot be applied repeatedly to cancer patients. Therefore, novel chemicals that enhance the efficacy of chemoradiotherapy (CRT) would be valuable. Here, we repor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.47

    authors: Ohno S,Naito Y,Mukai S,Yabuta N,Nojima H

    更新日期:2015-12-03 00:00:00

  • Rap1A protein interferes with various MAP kinase activating pathways in skeletal myogenic cells.

    abstract::Constitutive expression of the activated Rap1A protein inhibits differentiation of myogenic C2 cells whereas the inactivated Rap1A protein favours cell differentiation and induces late endocytic compartments clustering. Although the role of Rap1A in MAPK activation has been analysed in various cell types, the signalli...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203984

    authors: Pizon V,Baldacci G

    更新日期:2000-12-07 00:00:00

  • Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms.

    abstract::Mutant p53 frequently accumulates in cancer cells and promotes tumor cell invasion, as part of its gain of function. Its accumulation is partially due to enhanced stability, but little is known about how the mRNA levels of mutant p53 can be regulated. Likewise, the impact of cancer therapy on the levels of mutant p53 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.72

    authors: Bug M,Dobbelstein M

    更新日期:2011-08-18 00:00:00

  • Oncostatin M activates phosphatidylinositol-3-kinase in Kaposi's sarcoma cells.

    abstract::Oncostatin M (OM) is a polypeptide cytokine that induces autocrine and paracrine effects on AIDS-Kaposi's sarcoma (KS) cells (Nair et al., Science, 255, 1430-1432, 1992; Miles et al., Science, 255, 1432-1434, 1992). The signalling pathways underlying this activation are largely unknown. We have found that OM binding t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Soldi R,Graziani A,Benelli R,Ghigo D,Bosia A,Albini A,Bussolino F

    更新日期:1994-08-01 00:00:00

  • A possible role for c-Myc oncoproteins in post-transcriptional regulation of ribosomal RNA.

    abstract::Overexpression of members of the myc family of oncogenes contributes to the development of many vertebrate malignancies. Although several functions for myc gene products have been proposed, the targets for Myc activity during oncogenesis or normal development remain to be identified. Oocytes of Xenopus laevis, which a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Gibson AW,Ye R,Johnston RN,Browder LW

    更新日期:1992-11-01 00:00:00

  • Mouse models in tumor suppression.

    abstract::Genetic lesions found in tumors are often targeted to the negative growth regulatory tumor suppressor genes. Much of our understanding of tumor suppressor gene function is derived from experimental manipulations in cultured cells. Recently, however, the generation of mice with germ line tumor suppressor gene mutations...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1202573

    authors: Ghebranious N,Donehower LA

    更新日期:1998-12-24 00:00:00

  • Involvement of poly (ADP-ribose)-polymerase in the Pax-6 gene regulation in neuroretina.

    abstract::The quail Pax-6 gene is expressed from two promoters named P0 and P1. P0 promoter is under the control of a neuroretina-specific enhancer (EP). This enhancer activates the P0 promoter specifically in neuroretina cells and in a developmental stage-dependent manner. The EP enhancer binds efficiently, as revealed by sout...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202406

    authors: Plaza S,Aumercier M,Bailly M,Dozier C,Saule S

    更新日期:1999-01-28 00:00:00

  • CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3.

    abstract::Breast cancer is a heterogeneous genetic disease driven by the accumulation of individual mutations per tumor. Whole-genome sequencing approaches have identified numerous genes with recurrent mutations in primary tumors. Although mutations in well characterized tumor suppressors and oncogenes are overrepresented in th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0739-0

    authors: Block I,Müller C,Sdogati D,Pedersen H,List M,Jaskot AM,Syse SD,Lund Hansen P,Schmidt S,Christiansen H,Casella C,Bering Olsen S,Blomstrøm MM,Riedel A,Thomassen M,Kruse TA,Karlskov Hansen SW,Kioschis P,Mollenhauer J

    更新日期:2019-06-01 00:00:00

  • Ecotropic viral integration site 1, a novel oncogene in prostate cancer.

    abstract::Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer in men in the western world. Mutations in tumor suppressor genes and in oncogenes are important for PCa progression, whereas the role of stem cell proteins in prostate carcinogenesis is insufficiently examined. This study investigates the role o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.325

    authors: Queisser A,Hagedorn S,Wang H,Schaefer T,Konantz M,Alavi S,Deng M,Vogel W,von Mässenhausen A,Kristiansen G,Duensing S,Kirfel J,Lengerke C,Perner S

    更新日期:2017-03-01 00:00:00

  • EGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins.

    abstract::The overexpression or mutation of tyrosine kinases (TKs), such as the epidermal growth factor receptor (EGFR), can lead to the development of cancer. The most common mutation of the EGFR in glioblastomas is the deletion of exons 2-7 known as the EGFRvIII. This mutant receptor cannot bind EGF but, instead, is constitut...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209662

    authors: Davies GC,Ryan PE,Rahman L,Zajac-Kaye M,Lipkowitz S

    更新日期:2006-10-19 00:00:00

  • Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain.

    abstract::Internal tandem duplication (ITD) of the juxtamembrane (JM) domain of FLT3 is the most frequent mutation in human acute myeloid leukemia, and is significantly associated with leukocytosis and a poor prognosis. Previously we reported that FLT3 with ITD (FLT3/ITD) formed a homodimer and was autophosphorylated on tyrosin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205332

    authors: Kiyoi H,Ohno R,Ueda R,Saito H,Naoe T

    更新日期:2002-04-11 00:00:00

  • Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2.

    abstract::Cancer cells recruit monocytes, macrophages and other inflammatory cells by producing abundant chemoattractants and growth factors, such as macrophage colony-stimulating factor (M-CSF/CSF-1) and monocyte chemoattractant protein-1 (MCP-1/CCL2), to promote tumor growth and dissemination. An understanding of the mechanis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.112

    authors: Li Y,Cai L,Wang H,Wu P,Gu W,Chen Y,Hao H,Tang K,Yi P,Liu M,Miao S,Ye D

    更新日期:2011-09-08 00:00:00

  • Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways.

    abstract::Many of the signaling responses induced by transforming growth factor-beta (TGF-beta) are mediated by Smad proteins, but there is evidence that it can also signal independently of Smads. Here, we provide evidence that multiple signal pathways induced by TGF-beta1-including Src family tyrosine kinases (SFKs), generatio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210649

    authors: Joo CK,Kim HS,Park JY,Seomun Y,Son MJ,Kim JT

    更新日期:2008-01-24 00:00:00

  • The distinct capacity of Fyn and Lck to phosphorylate Sam68 in T cells is essentially governed by SH3/SH2-catalytic domain linker interactions.

    abstract::Sam68 phosphorylation correlates with Fyn but not Lck expression in T cells. This substrate has been used here to explore the possible basis of the specificity of Fyn versus Lck. We show that this specificity is not based on a spatial segregation of the two kinases, since a chimeric Lck molecule containing the membran...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205929

    authors: Feuillet V,Semichon M,Restouin A,Harriague J,Janzen J,Magee A,Collette Y,Bismuth G

    更新日期:2002-10-17 00:00:00

  • The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.

    abstract::Epidemiological studies have demonstrated a close association of type 2 diabetes and hepatocellular carcinoma (HCC). Exenatide (Ex-4), a potent diabetes drug targeting glucagon-like peptide-1 receptor (GLP-1R), is protective against non-alcoholic fatty liver disease (NAFLD). However, the Ex-4 function and GLP-1R statu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.38

    authors: Zhou M,Mok MT,Sun H,Chan AW,Huang Y,Cheng AS,Xu G

    更新日期:2017-07-20 00:00:00

  • Correlation between the conformational phenotype of p53 and its subcellular location.

    abstract::In order to obtain insight into the parameters determining the subcellular localization of mutant and wild-type forms of p53, we analysed the subcellular distribution of p53 in four Balb/c mouse-derived cell lines ranging in their cellular phenotypes from normal (3T3), via minimal transformant (T3T3), to maximally tra...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zerrahn J,Deppert W,Weidemann D,Patschinsky T,Richards F,Milner J

    更新日期:1992-07-01 00:00:00

  • CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration.

    abstract::CD44 is a cell surface receptor for hyaluronate, a component of the extracellular matrix (ECM). Although CD44 has been implicated in tumor invasion and metastasis, the molecular mechanisms remain to be elucidated. Here we find that CD44 expressed in cancer cells is cleaved at the membrane-proximal region of the ectodo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202447

    authors: Okamoto I,Kawano Y,Tsuiki H,Sasaki J,Nakao M,Matsumoto M,Suga M,Ando M,Nakajima M,Saya H

    更新日期:1999-02-18 00:00:00